Novel oral anticoagulants for stroke prevention in patients with atrial fibrillation: dawn of a new era.

about

Clinical utility of dabigatran in United Arab Emirates. A pharmacovigilance study.The Feinberg Award Lecture 2013: treatment of intracranial atherosclerosis: learning from the past and planning for the future.Atherosclerotic intracranial arterial stenosis: risk factors, diagnosis, and treatment

P2860

Q36356624-15912F2B-D24A-407F-85F3-BCA698539C27 Q37276835-74176BC8-AE69-441F-BC0E-804B23CFB6C7 Q37734702-D91D48D3-4C78-4272-A90B-B6648B9B6C93

P2860

Novel oral anticoagulants for stroke prevention in patients with atrial fibrillation: dawn of a new era.

Item

http://www.wikidata.org/entity/Q38079915

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Novel oral anticoagulants for ...... brillation: dawn of a new era.

@en

type

Item

label

Novel oral anticoagulants for ...... brillation: dawn of a new era.

@en

prefLabel

Novel oral anticoagulants for ...... brillation: dawn of a new era.

@en

P1476

Novel oral anticoagulants for ...... ibrillation: dawn of a new era

@en

P2093

Matthew W Martinez

http://www.w3.org/2001/XMLSchema#string

Tahmeed Contractor

http://www.w3.org/2001/XMLSchema#string

Vadim Levin

http://www.w3.org/2001/XMLSchema#string

P2860

Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation

Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis

Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects

Dabigatran versus warfarin in patients with atrial fibrillation

Dabigatran association with higher risk of acute coronary events: meta-analysis of noninferiority randomized controlled trials

Dabigatran etexilate--a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity

Validation of Clinical Classification Schemes for Predicting Stroke

Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

P304

34-44

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3810/PGM.2013.01.2622

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

125

http://www.w3.org/2001/XMLSchema#string

P50

Francis E. Marchlinski

P577

2013-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23391669

http://www.w3.org/2001/XMLSchema#string

P921

anticoagulation

Novel oral anticoagulants for stroke prevention in patients with atrial fibrillation: dawn of a new era.

about

P2860

P2860

Novel oral anticoagulants for stroke prevention in patients with atrial fibrillation: dawn of a new era.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921